BlackRock
CGTX icon

BlackRock’s Cognition Therapeutics CGTX Stock Holding History

BlackRock’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
1,261,993
+293,631
+30% +$348K ﹤0.01% 4245
2026
Q1 		$735K Sell
968,362
-45,976
-5% -$53.5K ﹤0.01% 4426
2025
Q4 		$1.37M Buy
1,014,338
+45,639
+5% +$74.1K ﹤0.01% 4221
2025
Q3 		$1.31M Buy
968,699
+891,844
+1,160% +$1.22M ﹤0.01% 4210
2025
Q2 		$23.8K Sell
76,855
-77,702
-50% -$26.2K ﹤0.01% 5120
2025
Q1 		$65K Sell
154,557
-1,482
-0.9% -$871 ﹤0.01% 4865
2024
Q4 		$109K Buy
156,039
+494
+0.3% +$244 ﹤0.01% 4770
2024
Q3 		$72.9K Buy
155,545
+2,964
+2% +$3.06K ﹤0.01% 4731
2024
Q2 		$253K Buy
152,581
+96,761
+173% +$193K ﹤0.01% 4502
2024
Q1 		$102K Buy
55,820
+211
+0.4% +$436 ﹤0.01% 4723
2023
Q4 		$103K Sell
55,609
-624
-1% -$825 ﹤0.01% 4794
2023
Q3 		$81K Sell
56,233
-2,184
-4% -$3.42K ﹤0.01% 4907
2023
Q2 		$107K Buy
58,417
+20,678
+55% +$43.8K ﹤0.01% 4893
2023
Q1 		$74.7K Buy
37,739
+1,122
+3% +$2.14K ﹤0.01% 5040
2022
Q4 		$76.9K Buy
36,617
+6,812
+23% +$13.8K ﹤0.01% 5118
2022
Q3 		$56K Buy
29,805
+2,296
+8% +$4.78K ﹤0.01% 5330
2022
Q2 		$58K Buy
27,509
+19,224
+232% +$49.7K ﹤0.01% 5379
2022
Q1 		$23K Buy
8,285
+288
+4% +$1.11K ﹤0.01% 5543
2021
Q4 		$51K Buy
+7,997
New +$78K ﹤0.01% 5395

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

BlackRock's CGTX Position: Q2 2026 in Review

BlackRock increased its Cognition Therapeutics (CGTX) stake by 30% in Q2 2026, buying an estimated $348K and bringing the position to 1,261,993 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #4245.

BlackRock first reported a position in CGTX in Q4 2021 and has held it in 19 quarters since. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

  • BlackRock held 1,261,993 shares of Cognition Therapeutics worth $1.45M as of Q2 2026.
  • BlackRock bought 293,631 Cognition Therapeutics shares in Q2 2026, an estimated $348K.
  • Cognition Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4245 holding.
  • BlackRock first reported a position in Cognition Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • 66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.